The dealmakers are gathering at JPM — are you on the list?

January 12 - 13, 2026 | 7:00 AM - 5:00 PM PT
Marriott Marquis, San Francisco

JPM isn't just about the panels — it's about who's in the room.

The executives finalizing their San Francisco plans now are the ones writing checks and shaping which companies make it through the funding crunch.

Endpoints at JPM is where real conversations happen, away from scripted pitches and crowded lobbies. The Endpoints Hub offers private meeting spaces, serious attendees, and a place where quick chats can turn into deals.

Planning to send a team? Buy a Group Pass and save 34% with early-bird pricing — a total savings of $900 (includes 3 tickets). Not sure who’s joining yet? Purchase now and assign attendees later.

CHOOSE YOUR PASS

Early Bird rates: Save $200 off single passes | Virtual passes are available at no charge

ON THE AGENDA

NEW: Featured conversation with Fred Ramsdell, Nobel laureate and scientific advisor
at Sonoma Biotherapeutics
NEW: Fireside chat with Heather Turner, CEO of LB Pharmaceuticals Inc
Fireside chat with Frank Jiang, EVP and chief strategy officer at Jiangsu Hengrui Pharmaceuticals

More details to come — stay tuned.

NEW: Fred Ramsdell
Nobel Laureate and Scientific Advisor
Sonoma Biotherapeutics

Heather Turner
CEO
LB Pharmaceuticals Inc

Frank Jiang
EVP, Chief Strategy Officer
Jiangsu Hengrui Pharmaceuticals

Endpoints at JPM26: Where biopharma goes to figure out what actually works now

We're drilling into the forces reshaping your business model: China's growing influence, regulatory upheaval, and a funding environment that's forcing everyone to rethink everything. How do we strike deals when buyers have all the leverage? Which strategies survive when funding plateaus? Find out — choose your pass now and be part of the action.